Company profile for Freya Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Freya Pharma Solutions, a late clinical stage biotech company focusing on the development of effective pharmaceutical therapies for women who have been diagnosed with Female Sexual Interest/Arousal Disorder (FSIAD), today announced to have reached agreement with shareholders on the acquisition of all intellectual property (IP), including all know-how and prior clinical trial results, for two therapies against FSIAD in clinical...
Freya Pharma Solutions, a late clinical stage biotech company focusing on the development of effective pharmaceutical therapies for women who have been diagnosed with Female Sexual Interest/Arousal Disorder (FSIAD), today announced to have reached agreement with shareholders on the acquisition of all intellectual property (IP), including all know-how and prior clinical trial results, for two therapies against FSIAD in clinical development, from Dutch Emotional Brain BV (EB).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Kraanspoor 50 ,1033 SE Amsterdam
Telephone
Telephone
+31 6 538 16 427
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/27/3195783/0/en/Freya-Pharma-Solutions-Rebrands-as-Arletta-Pharma-Solutions-Marking-New-Phase-in-Women-s-Healthcare-Innovation.html

GLOBENEWSWIRE
27 Nov 2025

https://www.globenewswire.com/news-release/2025/08/04/3126681/0/en/Freya-Pharma-Solutions-Announces-Launch-of-Phase-II-Clinical-Dose-Response-Study-testing-its-LybridoTM-Concept-Targeting-Female-Sexual-Dysfunction.html

GLOBENEWSWIRE
04 Aug 2025

https://www.globenewswire.com/news-release/2025/01/28/3016209/0/en/Freya-Pharma-Solutions-Strengthens-Leadership-with-Appointment-of-Distinguished-Supervisory-Board.html

GLOBENEWSWIRE
28 Jan 2025

https://www.prnewswire.com/news-releases/freya-pharma-solutions-announces-advice-from-the-fda-on-its-us-clinical-development-program-of-lybrido-for-the-treatment-of-female-sexual-interestarousal-disorder-301819298.html

PR NEWSWIRE
09 May 2023

https://www.prnewswire.com/news-releases/freya-pharma-solutions-appoints-christa-van-kan-as-director-clinical-operations-governing-the-companys-upcoming-confirmatory-clinical-development-program-using-lybrido-against-fsiad-301765654.html

PR NEWSWIRE
08 Mar 2023

https://www.prnewswire.com/news-releases/freya-pharma-solutions-innovative-compound-lybrido-for-the-treatment-of-female-sexual-dysfunction-well-received-at-european-society-for-sexual-medicine-congress-301752964.html

PR NEWSWIRE
22 Feb 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty